Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.

ECL's accelerating High-Tech, Digital and Life Sciences growth supports its outlook, but rising debt and financing costs keep the buy case cautious.

Church & Dwight Co., Inc. (NYSE:CHD) and The Clorox Company (NYSE:CLX) look quite different when it comes to dividends. CHD offers a much lower yield, but its dividend is growing faster. Clorox gives investors far more income today, though the company has been much more conservative with recent increases. Church & Dwight Co., Inc. (NYSE:CHD) […]

As Clorox has underperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

ENR trades at a steep discount, but weak earnings, margin pressure and soft battery demand challenge the case for a rebound.

Clorox’s second quarter generated a positive response from investors, as revenue surpassed analyst expectations despite a 2% year-over-year decline. Management attributed the quarter’s performance to targeted improvements in product superiority, focused brand investments, and effective promotional execution in key categories. CEO Linda Rendle noted that, “the majority of our businesses are performing at or above expectations,” while acknowledging operational challenges in segments like Litter an

GOJO acquisition boosts health segment as organic sales decline amid inflation headwinds.

The household cleaning and consumer products maker expects improvements through better planning, lower inventory levels and more automation.

Increasing energy, commodity and supplier costs are significant contributors, along with higher trucking, ocean freight and logistics-related expenses.

NWL vs. CLX: Which Stock Is the Better Value Option?

Clorox (NYSE:CLX) outlined its fiscal 2027 outlook, highlighting ongoing operational headwinds and inflation risks. The company is forecasting net sales growth of 13% to 14% for fiscal 2027, largely tied to the acquisition of GOJO Industries and the Purell brand. Clorox reported fiscal 2026 results that were in line with prior expectations and used the update to detail how the GOJO and Purell integration could affect future revenue and earnings. Clorox enters this update with the stock...

Clorox is a great value for income investors.

Companies In The News Are: ALSN, CLX, AEIS, PFE.

Clorox (CLX) could face slow underlying sales, lower margins and continued pressure in charcoal and

Clorox beats Q4 sales and earnings estimates as GOJO boosts sales, but lower volume and rising costs pressure margins and profits.

Clorox sees fiscal 2027 sales rising on GOJO and ERP comparisons, but inflation, muted categories and value-seeking consumers cloud the recovery.

The cleaning products maker expects adjusted earnings per share of $5.70 to $6.00 for the year, with most sales growth coming from its Purell acquisition

Moby summary of The Clorox Company's Q4 2026 earnings call

Clorox (NYSE:CLX) said it is entering fiscal 2027 with improving market-share trends, a completed enterprise resource planning implementation and a plan to offset more than $200 million in expected supply-chain inflation through productivity initiatives and targeted pricing. Chair and CEO Linda Ren

Although the revenue and EPS for Clorox (CLX) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Consumer products giant Clorox (NYSE:CLX) reported Q2 CY2026 results topping the market’s revenue expectations, but sales fell by 2% year on year to $1.95 billion. Its non-GAAP profit of $1.66 per share was 0.9% above analysts’ consensus estimates.

Clorox (CLX) delivered earnings and revenue surprises of +1.22% and +2.16%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

The company now expects sales to rise between 13% and 14% for the current fiscal year after its fourth-quarter revenue fell to $1.95 billion.

NWL's Q2 earnings beat and higher 2026 guidance strengthen its turnaround story, with sustained execution now key to the stock's next move.

Newell's discounted valuation, improving sales and margin recovery support the investment case, but debt and execution risks remain in focus.

NWL surges after an earnings beat and higher 2026 guidance as stronger sales and margins highlight its operating turnaround despite ongoing cost pressures.

The monthly jobs report comes out Friday. Before that, Elon Musk’s SpaceX will post its first earnings report as a listed company. Also reporting: Walt Disney; tech companies Palantir and Advanced Micro Devices; ride-sharing firms Uber and Lyft; private-equity firms Apollo, Carlyle and TPG; and fast-food chains McDonald's and Wendy’s.

Consumer products giant Clorox (NYSE:CLX) will be reporting results this Monday after market close. Here’s what investors should know.

Investing.com -- Here is your Pro Recap of the top takeaways from Wall Street analysts for the past week. InvestingPro subscribers always get first dibs on market-moving AI analyst comments. Upgrade today! Monday - Huntington Bancshares Incorporated (NASDAQ:HBAN) What’s the full story? Bank of America cuts Huntington Bancshares to Neutral from Buy, trimming its price target to $18.50. The post-merger dust from the Cadence conversion has cleared, but the valuation re-rating story just hit a wall.

(Bloomberg) -- Microsoft Corp. is on track to record the largest one-day increase in market value for any stock in history.Most Read from BloombergUS Strikes Iran Again as Conflict Spreads Across Middle EastWarner Bros. Deal Collapse Would Cost the Ellisons $9.8 BillionNasdaq 100 Gains 3% in AI Trade Revival After Rout: Markets WrapBond Yields at 19-Year High Send Warsh Credibility WarningMeta Falls After Defending AI Bets to Skeptical InvestorsShares of the Redmond, Washington-based company soa

Corporate earnings from big U.S. companies and closely-watched jobs reports are among the key updates for Wall Street this week. The latest batch of profit updates and forecasts could help give investors a clearer picture of how and where households are spending money amid stubbornly high inflation. Bleach and household products maker Clorox and hotel operator Marriott International report their latest results on Monday.

CLX Q4'26 results are expected to reflect y/y sales and earnings declines on ERP disruptions, cost inflation and sluggish category recoveries.

Clorox stock has had a tough run over the last five years, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiples now point to the shares trading at a discount to what the fundamentals suggest. Over the past 5 years, Clorox has delivered a total return decline of 27.9%, which leaves today’s share price around US$100.32 set against a weak long term result. Future cash flow potential from Clorox’s established household products portfolio can support the...

Recent analyst commentary around Clorox (CLX) has focused on expectations for a sharp year-over-year drop in earnings and revenue for the June 2026 quarter, which puts the upcoming August 3 earnings call in focus for investors. See our latest analysis for Clorox. Clorox shares have shown a modest positive trend in recent weeks, with a 7 day share price return of 4.84% and a 90 day share price return of 5.86%. However, the 1 year total shareholder return has declined 17.47%, which points to...

Clorox is facing expectations for a year-over-year earnings and revenue decline for its June 2026 quarter, with analysts forecasting quarterly earnings of US$1.64 per share and revenues of US$1.91 billion ahead of the August 3 earnings call that has now passed. An interesting angle is that the company’s weaker earnings outlook is accompanied by a bearish analyst stance, including a negative Earnings ESP and a lower independent ranking, which together highlight concerns about the near-term...

Energizer (ENR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls

Wall Street analysts are busy reshuffling their ratings ahead of the Fed meeting, with surprise double-upgrades, dramatic target cuts, and fresh initiations spanning surgical robots to cybersecurity. Find out which names made the biggest moves today.

REYN's pricing, innovation and productivity efforts are supporting performance, but commodity inflation and uneven demand keep the outlook balanced.

Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Clorox showered its owners with cash while the stock price sank. Here is the honest accounting of what that trade-off actually delivered, and what it means now.

Jim Cramer is flashing warning signs on semiconductor stocks and one high-flying AI name he says still has further to fall, but he sees two dividend stocks built to weather exactly this kind of chaos.

How do you find the best dividend stocks to buy? Income investors know there's no substitute for regular dividend increases over the long haul.

Pfizer, VICI Properties and General Mills lead the list of the highest-yielding dividend stocks in the S&P 500. Some of the other names might surprise you.

Helen of Troy's sales momentum is rebuilding on stronger brands, innovation and distribution, but tariffs and costs still cloud the earnings recovery.

CLX's Cleaning gains and innovation support Household strength, but Litter and Food weakness may limit broader growth.

A household name is on the discount rack, but slow progress and new pressures raise the question of whether this is a true bargain or just a broken business.